| Aug 28 |
Addex Stock Soars on Crucial Update From Indivior Research Deal
|
| Aug 27 |
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
|
| Jul 28 |
Wall Street Breakfast: The Week Ahead
|
| Jul 26 |
Indivior inks $86M multistate settlement over opioid crisis
|
| Jul 26 |
Indivior reaches $86 million opioid settlement with 16 US states
|
| Jul 26 |
Indivior: End Of Legal Challenges In Sight
|
| Jul 26 |
Indivior: Management Takes Advantage Of Sell-Off As Board Approves Another $100m Buyback
|
| Jul 25 |
Indivior PLC (INDV) Q2 2024 Earnings Call Transcript
|
| Jul 25 |
Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame
|
| Jul 25 |
Indivior Announces Q2 2024 Financial Results
|
